Acuta Capital Partners’s ESSA Pharma EPIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-232,896
| Closed | -$6.65M | – | 51 |
|
|
2021
Q2 | $6.65M | Sell |
232,896
-54,104
| -19% | -$1.55M | 2.66% | 11 |
|
|
2021
Q1 | $8.34M | Buy |
+287,000
| New | +$8.34M | 3.01% | 11 |
|
|
2017
Q3 | – | Sell |
-22,100
| Closed | -$242K | – | 41 |
|
|
2017
Q2 | $242K | Sell |
22,100
-8,165
| -27% | -$89.4K | 0.07% | 32 |
|
|
2017
Q1 | $1.88M | Hold |
30,265
| – | – | 0.44% | 30 |
|
|
2016
Q4 | $1.33M | Buy |
30,265
+930
| +3% | +$40.9K | 0.49% | 29 |
|
|
2016
Q3 | $1.68M | Buy |
29,335
+823
| +3% | +$47.1K | 0.63% | 35 |
|
|
2016
Q2 | $1.75M | Buy |
28,512
+5,145
| +22% | +$317K | 0.84% | 33 |
|
|
2016
Q1 | $1.52M | Buy |
23,367
+7,242
| +45% | +$472K | 0.85% | 27 |
|
|
2015
Q4 | $1.48M | Buy |
16,125
+1,705
| +12% | +$156K | 0.71% | 31 |
|
|
2015
Q3 | $1.8M | Buy |
+14,420
| New | +$1.8M | 1.04% | 32 |
|